Pharmaceutical Drug Targets and Diseases: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
David Canner (talk | contribs)
No edit summary
David Canner (talk | contribs)
No edit summary
Line 9: Line 9:
***[[Acetylcholinesterase]]
***[[Acetylcholinesterase]]
***[[2ace|Acetylcholinesterase from Torpedo Californica]]
***[[2ace|Acetylcholinesterase from Torpedo Californica]]
***[[Flexibility of aromatic residues in acetylcholinesterase|Flexibility of Aromatic Residues in AChE]]
***[[SANDBOX138|Human APP Intracellular Domain Complex with Fe65-PTB2]]
***[[Flexibility of aromatic residues in acetylcholinesterase|Aromatic Residue Flexibility in AChE]]
***[[Beta Amyloid]]
***[[Beta Amyloid]]
***[[Acetylcholine binding protein]]  (AChBP)
***[[Acetylcholine binding protein]]  (AChBP)

Revision as of 18:47, 30 September 2010

AstraZeneca’s Nexium

The following is a list of major pharmaceutical compound targets, drugs, and information organized by disease.

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

David Canner, Thomas J. Stout, Eran Hodis, Wayne Decatur, Alexander Berchansky